Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Experimental work using c-Fos immunoreactivity as a marker demonstrated that PT-141 can activate neurons in specific hypothalamic regions
If youre constantly hungry, low on energy, or stuck in cycles of losing and regaining weight, its time for a closer look
The ultimate classification of GLP-1 agonists as game-changing or overhyped will depend on societys ability to address the implementation challenges that currently limit their transformative potential
District Court for the Eastern District of Pennsylvania as part of a Glucagon-Like Peptide-1 Receptor Agonist Products Liability Litigation
US$ 29.31
US$ 28.61
US$ 28.63
US$ 26.75
